人体肠道菌群及其代谢物影响COVID-19及其并发症的免疫反应
研究对112例住院SARS-CoV-2感染患者与112例经重要混杂因素匹配的非COVID-19对照进行粪便宏基因组测序和代谢组学及血浆细胞因子检测,发现COVID-19相关微生物与肠道代谢物及炎症细胞因子 dynamics 之间存在多重关联,严重疾病和肺炎中关联明显,腹泻组罕见,提示COVID-19中存在肠-肺轴。
要点
- COVID-19相关微生物与肠道代谢物及炎症细胞因子 dynamics 存在多重关联,严重疾病和肺炎中关联明显。
- 微生物和代谢组改变在严重疾病中与随访数据部分一致,COVID-19微生物特征与类风湿关节炎重叠。
- 基于微生物组的随机森林分类器可高度预测COVID-19和严重疾病,香港与日本微生物特征中度一致。
核心结论
- 多组学分析揭示COVID-19及其相关并发症中存在多重肠道微生物-代谢物-细胞因子相互关系,但在胃肠道并发症中较少,提示微生物介导的免疫反应在不同器官部位存在差异。
- 结果强调COVID-19中存在肠-肺轴。
研究设计与样本
- 对112例住院SARS-CoV-2感染患者和112例经重要混杂因素匹配的非COVID-19对照个体的粪便进行鸟枪法宏基因组测序和代谢组学分析,并检测血浆细胞因子。
- 用随访数据、日本4D微生物组队列和非日本数据集验证结果。
主要发现
- COVID-19相关微生物(如口腔微生物和短链脂肪酸产生菌)与肠道代谢物(如支链和芳香族氨基酸、短链脂肪酸、碳水化合物、神经递质和维生素B6)之间存在多重相关性。
- 上述微生物和代谢物也与炎症细胞因子 dynamics(如干扰素γ、干扰素λ3、白细胞介素6、CXCL-9和CXCL-10)相关。
- 这些相互关系在严重疾病和肺炎中检测到较多,在高D-二聚体水平、肾功能不全和肝功能不全组中检测到中等程度,在腹泻组中罕见。
- 在COVID-19中确认了改变代谢物(如支链氨基酸、亚精胺、腐胺和维生素B6)与相应微生物功能基因的一致性。
- 来自横断面数据集的严重疾病微生物和代谢组改变结果与随访数据集部分一致。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: We investigate interrelationships between gut microbes, metabolites, and cytokines that characterize COVID-19 and its complications, and we validate the results with follow-up, the Japanese 4D (Disease, Drug, Diet, Daily Life) microbiome cohort, and non-Japanese data sets. METHODS: We performed shotgun metagenomic sequencing and metabolomics on stools and cytokine measurements on plasma from 112 hospitalized patients with SARS-CoV-2 infection and 112 non-COVID-19 control individuals matched by important confounders. RESULTS: Multiple correlations were found between COVID-19-related microbes (eg, oral microbes and short-chain fatty acid producers) and gut metabolites (eg, branched-chain and aromatic amino acids, short-chain fatty acids, carbohydrates, neurotransmitters, and vitamin B6). Both were also linked to inflammatory cytokine dynamics (eg, interferon γ, interferon λ3, interleukin 6, CXCL-9, and CXCL-10). Such interrelationships were detected highly in severe disease and pneumonia; moderately in the high D-dimer level, kidney dysfunction, and liver dysfunction groups; but rarely in the diarrhea group. We confirmed concordances of altered metabolites (eg, branched-chain amino acids, spermidine, putrescine, and vitamin B6) in COVID-19 with their corresponding microbial functional genes. Results in microbial and metabolomic alterations with severe disease from the cross-sectional data set were partly concordant with those from the follow-up data set. Microbial signatures for COVID-19 were distinct from diabetes, inflammatory bowel disease, and proton-pump inhibitors but overlapping for rheumatoid arthritis. Random forest classifier models using microbiomes can highly predict COVID-19 and severe disease. The microbial signatures for COVID-19 showed moderate concordance between Hong Kong and Japan. CONCLUSIONS: Multiomics analysis revealed multiple gut microbe-metabolite-cytokine interrelationships in COVID-19 and COVID-19related complications but few in gastrointestinal complications, suggesting microbiota-mediated immune responses distinct between the organ sites. Our results underscore the existence of a gut-lung axis in COVID-19.
引用
- Nagata N, Takeuchi T, Masuoka H, et al. Human Gut Microbiota and Its Metabolites Impact Immune Responses in COVID-19 and Its Complications. Gastroenterology. 2022. PMID: 36155191. doi:10.1053/j.gastro.2022.09.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。